Cholinesterase inhibitors in people with dementia with Lewy bodies and cardiac conduction abnormalities.

Kalam S, Stellman J, Bell R, Abdelnour C, Weil RS

Open source

DOI
10.1016/s1474-4422(26)00231-0
Published
2026 Sep
Container
The Lancet. Neurology
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s1474-4422-26-00231-0,
  title = {Cholinesterase inhibitors in people with dementia with Lewy bodies and cardiac conduction abnormalities.},
  author = {Kalam S and Stellman J and Bell R and Abdelnour C and Weil RS},
  year = {2026},
  journal = {The Lancet. Neurology},
  doi = {10.1016/s1474-4422(26)00231-0},
  url = {https://doi.org/10.1016/s1474-4422(26)00231-0}
}

RIS

TY  - JOUR
TI  - Cholinesterase inhibitors in people with dementia with Lewy bodies and cardiac conduction abnormalities.
AU  - Kalam S
AU  - Stellman J
AU  - Bell R
AU  - Abdelnour C
AU  - Weil RS
PY  - 2026
JO  - The Lancet. Neurology
DO  - 10.1016/s1474-4422(26)00231-0
UR  - https://doi.org/10.1016/s1474-4422(26)00231-0
ER  - 

APA

S, K., J, S., R, B., C, A., & RS, W. (2026). Cholinesterase inhibitors in people with dementia with Lewy bodies and cardiac conduction abnormalities.. The Lancet. Neurology. https://doi.org/10.1016/s1474-4422(26)00231-0

Source records